×

Do you want to link to this External Site and leave Amgen.com?

YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

Press Release

View printer-friendly version
Amgen to Present at the 28th Annual Cowen Healthcare Conference and the 11th Annual Lehman Brothers Global Healthcare Conference

THOUSAND OAKS, Calif.--(BUSINESS WIRE)--March 14, 2008--Amgen (NASDAQ:AMGN) will present at the 28th Annual Cowen Healthcare Conference on Tuesday, March 18, 2008 at the Boston Marriott Copley Place, Boston, Mass., beginning at 9:30 a.m. Eastern Time. Amgen will also present at the 11th Annual Lehman Brothers Global Healthcare Conference on Wednesday, March 19, 2008, at the Loews Miami Beach Hotel in Miami, Fla., beginning at 8:00 a.m. Eastern Time. Amgen Executive Vice President of Research and Development Roger M. Perlmutter, M.D., Ph.D. will present at both conferences. Live audio of the presentations will be available over the Internet and can be accessed from Amgen's Web site, www.amgen.com, under Investors.

Information regarding presentation time, webcast availability, and webcast links are available on Amgen's Investor Relations Events Calendar.

About Amgen

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com.

CONTACT: Amgen, Thousand Oaks
David Polk, 805-447-4613 (media)
Cory Rivera, 805-447-1060 (investors)

SOURCE: Amgen